Skip to main content
Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke

Fig. 8

Immunofluorescent staining for the viability of SB623 cells in the healthy rat after intracerebral transplantation. a Immunofluorescent staining for STEM121/DAPI double-positive cells in the healthy rat shows SB623 cells at day 3 after intracerebral transplantation (white arrow) (top: low magnification, bottom: high magnification). Scale bar = 100 μm. b ANOVA revealed that the number of STEM121-positive cells at day 3 after transplantation was significantly higher than that at day 7 and day 14 (each group: n = 6) (F(2, 15) = 264, p < 0.001) (mean ± SE, **p < 0.01 vs. day 3 group, #p < 0.05 vs. day 14 group). Abbreviation: DAPI: 4′ 6-diamidino-2-phenylindole

Back to article page